Having trouble viewing this email? View in your browser.
ESCMID Logo

13 October 2020
WEEKLY NEWS

Dear colleagues,

Please find below the latest edition of ESCMID Weekly News.

With kind regards,
ESCMID Executive Office.

 

Catch selected ECCVID highlights on YouTube

Selected ECCVID sessions have been made available on the ESCMID YouTube channel

Find highlights from sessions by Marion Koopmans, Andrea Ammon, Maria van Kerkhove and David Fisman among the videos!

To access all of the ECCVID material on-demand, visit the ECCVID website and register. The sessions will remain live until December 25, 2020.
 

› Read more

Application period for 50 ESCMID funded observerships will end in two days!

Apply now for one of the 50 ESCMID funded observerships. All ESCMID Young Scientists Members are invited to submit their documents and at the link below you will find the full eligibility criteria for the prestigious observerships programme. Applications can be submitted until 15 October 2020 12:00 CEST.

In case of questions to the ESCMID observership programme, please contact: observership@escmid.org 

› Read more

The role of health care workers during COVID-19

The Professional Affairs Subcommittee (PAS) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) has developed a survey in order to determine the impact of the first wave of the COVID-19 pandemic on institutions across the world, from the point of view of their health care workers, regardless of whether they work in Infectious Diseases, Clinical Microbiology or in other specialties.

First results of the survey will be published at the 4th Professional Affairs Workshop (PAW 2020) in November 2020 and people can participate until 20 October 2020 by following the link below.

› Read more
 

Patient and Public Involvement in Antimicrobial Research

A team of researchers from North Bristol NHS Trust and the University of the West of England in the UK who are partners in the COMBACTE (Combatting Bacterial Resistance in Europe) project, has been working to develop Patient and Public Involvement (PPI) in research within COMBACTE.

Public involvement (PI) can be defined as an active collaboration between researchers and the public (including patients and carers) throughout the medicine development lifecycle and medical research.

You are hereby invited to take part into a PPI survey in order for the team to learn more about current understanding and perceptions of PPI in antimicrobial research, as well as practical experience, both in the UK and across Europe. Even if you have limited or no experience of PI, any information and opinions that you are able to share is useful. The survey will take 10 minutes to complete.

The results of the survey will be analyzed and used in a report to the COMBACTE network which will also be made available on the University of the West of England’s open-access repository. The anonymised results may also be used in conference papers and peer-reviewed academic papers. The survey is open until October 16.

› Read more
 

Wellcome trust survey: Antimicrobial prescribing in high, low and middle income countries

The Drug Resistant Infections team at Wellcome has launched a survey aimed at collecting data on current prescribing practices in both high, and low and middle-income countries. The data collected through the survey will be pivotal to help Wellcome understand clinical and public health gaps and prioritise its funding towards areas of critical need.

If you are a healthcare worker who routinely prescribe antimicrobial agents, we need your help. You are kindly invited to participate in the survey which can be accessed here.

Please note that the survey will close on 20 October 2020.

› Read more
 

CMI highlight: Seroprevalence of SARS-CoV-2 immunoglobulin antibodies in Wuhan, China: part of the city-wide massive testing campaign

In mid-May 2020, Wuhan launched a population-scale city-wide SARS-CoV-2 testing campaign, which aimed to perform nucleic acid and viral antibody testing for citizens in Wuhan. Here the screening results of cluster sampled 61,437 residents in the Wuchang District of Wuhan are presented. 

Around 2% of the individuals screened was detected positive for at least one antiviral antibody and only the 0.08% of them were found positive for both antibodies. Interestingly, the positive rate of female carriers of antibodies were higher than those of male counterparts, especially in elderly citizens, indicating a sexual discrepancy in seroprevalence. In conclusion, the seroprevalence of SARS-CoV-2 in Wuhan resulted low, indicating that most of Wuhan residents are still susceptible to this virus.

› Read more
ESCMID Executive Office
P.O. Box 214
4010 Basel
Switzerland
Phone +41 61 5080 173
info@escmid.org
www.escmid.org
Follow ESCMID
Visit us on LinkedIn Visit us on YouTube
 
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.